BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34560179)

  • 21. Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references.
    Clouet E; Kerdine-Römer S; Ferret PJ
    Toxicol In Vitro; 2017 Dec; 45(Pt 3):374-385. PubMed ID: 28539215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive-capacity.
    Teunis MA; Spiekstra SW; Smits M; Adriaens E; Eltze T; Galbiati V; Krul C; Landsiedel R; Pieters R; Reinders J; Roggen E; Corsini E; Gibbs S
    ALTEX; 2014; 31(3):251-68. PubMed ID: 24535238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
    Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
    J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of in vitro assays for the assessment of the skin sensitization hazard of functional polysiloxanes and silanes.
    Petry T; Bosch A; Coste X; Eigler D; Germain P; Seidel S; Jean PA
    Regul Toxicol Pharmacol; 2017 Mar; 84():64-76. PubMed ID: 28017767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin Sensitization Tests: The LLNA and the RhE IL-18 Potency Assay.
    Corsini E; Gibbs S; Roggen E; Kimber I; Basketter DA
    Methods Mol Biol; 2021; 2240():13-29. PubMed ID: 33423223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an artificial neural network model for risk assessment of skin sensitization using human cell line activation test, direct peptide reactivity assay, KeratinoSens™ and in silico structure alert parameter.
    Hirota M; Ashikaga T; Kouzuki H
    J Appl Toxicol; 2018 Apr; 38(4):514-526. PubMed ID: 29226339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human potency predictions for aldehydes using the local lymph node assay.
    Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
    Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
    Dimitrov S; Detroyer A; Piroird C; Gomes C; Eilstein J; Pauloin T; Kuseva C; Ivanova H; Popova I; Karakolev Y; Ringeissen S; Mekenyan O
    J Appl Toxicol; 2016 Dec; 36(12):1568-1578. PubMed ID: 27080242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of amino acid derivative reactivity assay (4 mM) for the prediction of skin sensitization by combining multiple alternative methods to evaluate key events.
    Imamura M; Yamamoto Y; Fujita M; Wanibuchi S; Nakashima N; Kojima H; Ono A; Kasahara T
    J Appl Toxicol; 2022 Jul; 42(7):1159-1167. PubMed ID: 34993977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
    Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
    Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
    Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
    Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
    Takeyoshi M; Iida K; Suzuki K; Yamazaki S
    J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitization potency. Part 1. Underlying physical organic chemistry principles and the extent to which they are represented in the LLNA validation dataset.
    Roberts DW; Api AM; Patlewicz G; Schultz TW
    Regul Toxicol Pharmacol; 2016 Oct; 80():247-54. PubMed ID: 27424000
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
    Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
    Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.